Head of Investor Relations
Lineage Cell Therapeutics, Inc. (LCTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Lineage Cell Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get LCTX alertsIoana Hone is recorded as Head of Investor Relations at Lineage Cell Therapeutics, Inc. (LCTX). Ioana Hone has spoken on 22 earnings calls across 1 company, most recently for Lineage Cell Therapeutics, Inc. on August 6, 2026. Lineage Cell Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lineage Cell Therapeutics, Inc. includes Brian M. Culley (CFO and Board Member), Jill A. Howe (CFO and Board Member), Alexandra Hernandez (Chief Accounting Officer) and 7 others.
“A press release reporting our second quarter 2026 financial results was issued earlier today, August 6, 2026, and can be found on the Investors section of our website.”
“A press release reporting our first quarter 2026 financial results was issued earlier today, May 12, 2026, and can be found on the Investors section of our website.”
“A press release reporting our fourth quarter and full year 2025 financial results was issued earlier today, March 5, 2026, and can be found on the Investors section of our website.”
“A press release reporting our third quarter 2025 financial results was issued earlier today, November 6, 2025, and can be found on the Investors section of our website.”
“A press release reporting our second quarter 2025 financial results was issued earlier today, August 12, 2025, and can be found on the Investors section of our website.”
Biotechnology · Healthcare
Head of Investor Relations
